Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Patients who are immunocompromised (IC) are at increased risk of Clostridium difficile infection (CDI), which has increased to epidemic proportions over the past decade. Fecal microbiota transplantation (FMT) appears effective for the treatment of CDI, although there is concern that IC patients may be at increased risk of having adverse events (AEs) related to FMT. This study describes the multicenter experience of FMT in IC patients.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Am. J. Gastroenterol.

Title: The American journal of gastroenterology

ISSN (Electronic): 1572-0241

ISSN (Print): 0002-9270

Publication date (Electronic): Jul 2014

Volume: 109

Issue: 7

Affiliations

[1 ] Division of Gastroenterology, Brown Alpert Medical School, Women's Medicine Collaborative, Alpert Medical School of Brown University, Providence, Rhode Island, USA.

[2 ] Indiana University School of Medicine, Indianapolis, Indiana, USA.

[3 ] University of Minnesota Medical School, Minneapolis, Minnesota, USA.

[4 ] University of Washington School of Medicine, Seattle, Washington, USA.

[5 ] Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.

[6 ] Lahey Clinic Hospital and Medical Center, Tufts University School of Medicine, Burlington, Massachusetts, USA.

[7 ] Centre for Digestive Diseases, Five Dock, Sydney, New South Wales, Australia.

[8 ] Northern California Gastroenterology Consultants, Inc., Oakland, California, USA.

[9 ] California Pacific Medical Center, San Francisco, California, USA.

[10 ] Virginia Mason Medical Center, Seattle, Washington, USA.

[11 ] Massachusetts General Hospital and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

[12 ] University of Alberta, Edmonton, Alberta, Canada.

[13 ] University of Michigan, Ann Arbor, Michigan, USA.

[14 ] Integris Baptist Medical Center, Oklahoma, Oklahoma, USA.

[15 ] Ochsner Clinic Foundation, New Orleans, Louisiana, USA.

[16 ] Seattle Children's Hospital, Seattle, Washington, USA.

Article

Publisher Item ID: ajg2014133

DOI: 10.1038/ajg.2014.133

PubMed ID: 24890442

SO-VID: 7ada092e-60d4-4fb4-92fa-7ec7d9e25685

History

Data availability:

Comments

Comment on this article

scite_

Cited by 233

See all cited by